Oncolytics Biotech Inc.

NASDAQ:ONCY

Biotechnology

Healthcare
$0.50 +3.03%

+$0.03 today

Market cap
$50.41M
Beta
1.08
P/E (TTM)
-4.3
EPS (TTM)
-$0.32
52W Low $0.56High $1.51

Volume 0.38M

Average 1.26M

Balance Sheet

Inspect the capital base behind the business.

Assets

$10.40M

FY 2025 · Annual

-48.5% YoY

Liabilities

$15.62M

FY 2025 · Annual

+9.9% YoY

Equity

-$5.21M

FY 2025 · Annual

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents41.26M11.67M34.91M15.94M7.14M
Short-term Investments020.47M000
Net Receivables866K521K15K68K786.23K
Inventory00000
Other Current Assets000980K0
Total Current Assets44.9M35.68M38.17M18.88M9.39M
Property, Plant & Equipment (Net)976K652K647K1.31M1.01M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets0998K000
Total Non-current Assets976K1.65M647K1.31M1.01M
Total Assets45.88M37.33M38.82M20.19M10.4M
Account Payables594K2.25M1.08M1.09M4.81M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities408K79K532K1.62M3.3M
Total Current Liabilities2.69M3.95M4.24M6.69M8.37M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)6.73M6.73M6.73M6.73M6.74M
Other Non-current Liabilities00000
Total Non-current Liabilities7.09M6.89M7.02M7.52M7.24M
Total Liabilities9.78M10.83M11.26M14.2M15.62M
Common Stock391.35M404.04M430.91M438.19M0
Retained Earnings(393.42M)(418.25M)(446M)(477.71M)(589.32M)
Accumulated OCI388K662K544K961K8.54M
Other Stockholders Equity3.62M0000
Minority Interest00000
Total Equity36.1M26.5M27.56M5.98M(5.21M)
Total Debt655K373K423K1.06M772.51K
Net Debt(40.61M)(11.29M)(34.49M)(14.88M)(6.37M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$5.5M
Receivables$961.0K
Other Current$1.0M
Total Current Assets$7.5M
PP&E (Net)$674.0K
Total Non-current Assets$674.0K
Total Assets$8.2M

Analysis

Selected assets total $8.2M for Latest. The largest visible component is Cash & Equivalents at $5.5M, about 67.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 20, 2026
8-KCurrent reportOct 14, 2026
8-KCurrent reportOct 13, 2026
DEFA14ADEFA14A filingOct 6, 2026
DEF 14ADEF 14A filingOct 6, 2026

How much cash does ONCY have?

Oncolytics Biotech Inc. (ONCY) reported $7.14M in cash and equivalents in fiscal 2025.

How much debt does ONCY carry?

Oncolytics Biotech Inc. (ONCY) reported $772,509.00 of total debt, with net debt of -$6.37M.